Isospaglumic Acid

Isospaglumic Acid

SCHEMBL6438535

CC(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)O.[MgH2]

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GNPAT O15228 1/20 0.68
FOLH1 Q04609 8/20 0.55
NAALAD2 Q9Y3Q0 2/20 0.55
RIMKLA Q8IXN7 1/20 0.55
BMP1 P13497 2/20 0.47
KDM4E B2RXH2 1/20 0.46
MAPT P10636 1/20 0.46
THRB P10828 1/20 0.46
ALOX15 P16050 1/20 0.46
NFKB1 P19838 1/20 0.46
PTGS2 P35354 1/20 0.46
THPO P40225 1/20 0.46
RECQL P46063 1/20 0.46
BLM P54132 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ALDH1A1 P00352 1/20 0.44
GGH Q92820 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isospaglumic Acid SCHEMBL31121839 0.98 GNPAT (0.70) GNPATFOLH1NAALAD2RIMKLABMP1
SCHEMBL31194414 0.98 GNPAT (0.70) GNPATFOLH1NAALAD2RIMKLABMP1
Isospaglumic Acid SCHEMBL288514 0.98 GNPAT (0.70) GNPATFOLH1NAALAD2RIMKLABMP1
Isospaglumic Acid SCHEMBL288515 0.98 GNPAT (0.70) GNPATFOLH1NAALAD2RIMKLABMP1
Isospaglumic Acid SCHEMBL27542882 0.98 GNPAT (0.70) GNPATFOLH1NAALAD2RIMKLABMP1
SCHEMBL29517621 0.92 GNPAT (0.63) GNPATFOLH1NAALAD2RIMKLABMP1
SCHEMBL13467302 0.91 GNPAT (0.60) GNPATFOLH1NAALAD2RIMKLABMP1
SCHEMBL17950968 0.91 GNPAT (0.60) GNPATFOLH1NAALAD2RIMKLABMP1
SCHEMBL19106177 0.91 GNPAT (0.60) GNPATFOLH1NAALAD2RIMKLABMP1
SCHEMBL2248714 0.91 GNPAT (0.60) GNPATFOLH1NAALAD2RIMKLABMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050222193-A1 Novel combination for the treatment of airway disorders ALTANA PHARMA AG (DE) 2005-10-06 US disclosed
WO-2005074932-A1 THE USE OF (S) - PANTOPRAZOLE MAGNESIUM FOR THE TREATMENT OF AIRWAY DISORDERS ALTANA PHARMA AG (DE) 2005-08-18 WO disclosed
US-20050165041-A1 Combination for the treatment of airway disorders ALTANA PHARMA AG (DE) 2005-07-28 US disclosed
EP-1517706-A2 COMBINATION OF A PROTON PUMP INHIBITOR AND A RESPIRATORY AGENT FOR THE TREATMENT OF RESPIRATORY DISEASES ALTANA Pharma AG (DE) 2005-03-30 EP disclosed
EP-1506016-A2 NEW COMBINATION OF REVERSIBLE PROTON PUMP INHIBITORS AND AIRWAY THERAPEUTICS FOR TREATING AIRWAY DISORDERS ALTANA Pharma AG (DE) 2005-02-16 EP disclosed
WO-2003094967-A2 NEW COMBINATION OF REVERSIBLE PROTON PUMP INHIBITORS AND AIRWAY THERAPEUTICS FOR TREATING AIRWAY DISORDERS ALTANA PHARMA AG (DE) 2003-11-20 WO disclosed
WO-2003094968-A2 COMBINATION OF A PROTON PUMP INHIBITOR AND A RESPIRATORY AGENT FOR THE TREATMENT OF RESPIRATORY DISEASES ALTANA PHARMA AG (DE) 2003-11-20 WO disclosed